IP Library › Assignment 035108/0474
Patent Assignment
Reel/Frame 035108/0474

Release of Security Interest

Recorded: 2015-03-06 Pages: 50
Assignor
U.S. BANK NATIONAL ASSOCIATION
Executed: 2015-03-06
Assignees
ROMARK LABORATORIES, L.C.
300 BAYPORT DRIVE, SUITE 200, TAMPA, FLORIDA, 33607
ROMARK MANUFACTURING, LLC
300 BAYPORT DRIVE, SUITE 200, TAMPA, FLORIDA, 33607
LAPICOR, N.V.
ROOSVELD 2/6, 3400 LANDEN, BELGIUM
Covered Properties (25)
Use of Thiazolide Compounds for the Prevention and Treatment of Viral Diseases, Cancer and Diseases Caused by Intracellular Infections
Composition and Galenic Formulation Suitable for Combatting Affections of the Lower Abdomen
Patent: 5,387,598 →
Application: 08/227,033 →
Benzamide Derivatives
Patent: 5,578,621 →
Application: 08/301,407 →
Method for Treatment of Helicobacter Pylori Infections
Patent: 5,859,038 →
Application: 08/644,153 →
Antiviral Composition
Patent: 5,886,013 →
Application: 08/847,130 →
Pharmaceutical Compositions of Tizoxanide and Nitazoxanide
Patent: 5,968,961 →
Application: 08/852,447 →
Method Treatment of Opportunistic Infections with Pharmaceutical Compositions of Tizoxanide and Nitazoxanide
Patent: 5,965,590 →
Application: 08/887,809 →
Method for Treatment of Trematodes with Pharmaceutical Compositions of Tizoxanide and Nitazoxanide
Patent: 5,856,348 →
Application: 08/887,810 →
Method for Treatment of Equine Protozoal Myeloencephalitis with Thiazolides
Patent: 5,935,591 →
Application: 09/007,653 →
Acid Stabilized Pharmaceutical Compositions of Tizoxanide and Nitazoxanide
Patent: 6,117,894 →
Application: 09/073,436 →
Synthesis of Aryl Glucuronide of 2-Hydroxy-N- (5-Nitro-2-Thiazolyl) Benzamide, and Pharmaceutical Compositions Comprising Same
Patent: 5,925,622 →
Application: 09/114,596 →
2-(Hydroxy)-N-(5-Nitro-2-Thiazolyl)Benzamide
Patent: 6,020,353 →
Application: 09/170,697 →
Halogenated Benzamide Derivatives
Patent: 7,285,567 →
Application: 11/221,256 →
Publication: US 2006/0089396
Viral hepatitis treatment
Patent: 8,633,230 →
Application: 11/651,672 →
Publication: US 2007/0167504
Halogenated Benzamide Derivatives
Patent: 7,645,783 →
Application: 11/865,532 →
Publication: US 2008/0096941
Halogenated Benzamide Derivatives
Patent: 7,550,493 →
Application: 11/865,541 →
Publication: US 2008/0097106
Alkylsulfonyl-Substituted Thiazolide Compounds
Patent: 8,124,632 →
Application: 12/184,760 →
Publication: US 2009/0036467
Controlled Release Pharmaceutical Formulations of Nitazoxanide
Patent: 8,524,278 →
Application: 12/656,704 →
Publication: US 2010/0209505
Haloalkyl Heteroaryl Benzamide Compounds
Patent: 8,846,727 →
Application: 12/777,383 →
Publication: US 2010/0292274
Compounds and Methods for Treating Influenza
Patent: 9,023,877 →
Application: 12/821,571 →
Publication: US 2010/0330173
Pharmaceutical Compositions and Methods of Use of Salicylanilides for Treatment of Hepatitis Viruses
Application: 13/284,232 →
Publication: US 2012/0108592
Alkylsulfinyl-Substituted Thiazolide Compounds
Patent: 8,772,502 →
Application: 13/284,242 →
Publication: US 2012/0108591
Alkylsulfonyl-Substituted Thiazolide Compounds
Patent: 8,895,752 →
Application: 13/353,686 →
Publication: US 2012/0122939
Use of Thiazolide Compounds for the Prevention and Treatment of Viral Diseases, Cancer and Diseases Caused by Intracellular Infections
Application: 13/471,948 →
Publication: US 2012/0294831
Controlled Release Pharmaceutical Formulations of Nitazoxanide
Patent: 9,351,937 →
Application: 13/954,184 →
Publication: US 2014/0065215
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Security Interest Jul 12, 2005
From: ROMARK LABORATORIES, L.C.
To: CARDINAL HEALTH, INC.
Reel/Frame 016513/0360 →
Security Agreement Sep 26, 2006
From: ROMARK LABORATORIES, L.C.
To: MERRILL LYNCH CAPITAL, A DIVISION OF MERRILL LYNCH BUSINESS FINANCIAL SERVICES, INC.
Reel/Frame 018303/0163 →
Assignment of Assignor's Interest Oct 24, 2006
From: ROSSIGNOL, JEAN-FRANCOIS
To: ROMARK LABORATORIES, L.C.
Reel/Frame 018428/0233 →
Termination of Security Interest Mar 22, 2007
From: MERRILL LYNCH CAPITAL, A DIVISION OF MERRILL LYNCH BUSINESS FINANCIAL SERVICES, INC.
To: ROMARK LABORATORIES, L.C.
Reel/Frame 019047/0410 →
Notice of Grant of Security Interest Mar 23, 2007
From: ROMARK LABORATORIES, L.C.
To: LAMINAR DIRECT CAPITAL L.P., AS COLLATERAL AGENT
Reel/Frame 019055/0317 →
Assignment of Assignor's Interest Jan 14, 2008
From: ROSSIGNOL, JEAN FRANCOIS
To: ROMARK LABORATORIES L.C.
Reel/Frame 020358/0660 →
Assignment of Assignor's Interest Jan 14, 2008
From: ROSSIGNOL, JEAN FRANCOIS
To: ROMARK LABORATORIES L.C.
Reel/Frame 020358/0710 →
Assignment of Assignor's Interest Sep 5, 2008
From: ROSSIGNOL, JEAN-FRANCOIS
To: ROMARK LABORATORIES, L.C.
Reel/Frame 021487/0446 →
Assignment of Assignor's Interest Sep 15, 2008
From: ROSSIGNOL, JEAN-FRANCOIS; SEMPLE, J. EDWARD
To: ROMARK LABORATORIES L.C.
Reel/Frame 021530/0305 →
Notice of Grant of Security Interest in Patents Sep 28, 2009
From: ROMARK LABORATORIES, L.C.
To: LAMINAR DIRECT CAPITAL, L.L.C., AS COLLATERAL AGENT
Reel/Frame 023282/0880 →
Assignment of Assignor's Interest Feb 12, 2010
From: ROSSIGNOL, JEAN-FRANCOIS; AYERS, MARC
To: ROMARK LABORATORIES L.C.
Reel/Frame 023976/0831 →
Assignment of Assignor's Interest May 11, 2010
From: ROSSIGNOL, JEAN-FRANCOIS; SEMPLE, J. EDWARD
To: ROMARK LABORATORIES L.C.
Reel/Frame 024364/0392 →
Assignment of Assignor's Interest Jul 26, 2010
From: ROSSIGNOL, JEAN-FRANCOIS; SEMPLE, J. EDWARD
To: ROMARK LABORATORIES L.C.
Reel/Frame 024737/0670 →
Assignment of Assignor's Interest Jul 14, 2011
From: ROSSIGNOL, JEAN-FRANCOIS
To: ROMARK LABORATORIES L.C.
Reel/Frame 026589/0102 →
Release of Security Interest Jul 15, 2011
From: CARDINAL HEALTH, INC.
To: ROMARK LABORATORIES, L.C.
Reel/Frame 026595/0901 →
Change of Name Jul 29, 2011
From: LAMINAR DIRECT CAPITAL L.P.
To: LAMINAR DIRECT CAPITAL, L.L.C. (FORMERLY KNOWN AS LAMINAR DIRECT CAPITAL L.P.)
Reel/Frame 026676/0386 →
Release of Security Interest Jul 29, 2011
From: LAMINAR DIRECT CAPITAL, L.L.C. (SUCCESSOR IN INTEREST TO LAMINAR DIRECT CAPITAL L.P.)
To: ROMARK LABORATORIES, L.C.
Reel/Frame 026676/0482 →
Security Agreement Jul 29, 2011
From: ROMARK LABORATORIES, L.C.
To: PAUL CAPITAL FUND MANAGEMENT, L.L.C.
Reel/Frame 026676/0635 →
Change of Name Jul 29, 2011
From: LAMINAR DIRECT CAPITAL L.P.
To: LAMINAR DIRECT CAPITAL, L.L.C.
Reel/Frame 026676/0247 →
Release of Security Interest Jul 29, 2011
From: LAMINAR DIRECT CAPITAL, L.L.C. (FORMERLY KNOWN AS LAMINAR DIRECT CAPITAL L.P.)
To: ROMARK LABORATORIES, L.C.
Reel/Frame 026676/0576 →
Assignment of Assignor's Interest Jan 10, 2012
From: SEMPLE, J. EDWARD; ROSSIGNOL, JEAN-FRANCOIS
To: ROMARK LABORATORIES, L.C.
Reel/Frame 027505/0508 →
Assignment of Assignor's Interest Jan 10, 2012
From: SEMPLE, J. EDWARD; ROSSIGNOL, JEAN-FRANCOIS
To: ROMARK LABORATORIES, L.C.
Reel/Frame 027505/0483 →
Release of Security Interest Sep 3, 2013
From: PAUL CAPITAL FUND MANAGEMENT, L.L.C.
To: ROMARK LABORATORIES, L.C.
Reel/Frame 031159/0636 →
Security Agreement Sep 4, 2013
From: ROMARK LABORATORIES, L.C.; ROMARK MANUFACTURING, LLC; LAPICOR, N.V.
To: U.S. BANK NATIONAL ASSOCIATION
Reel/Frame 031156/0923 →
Security Interest Dec 22, 2017
From: ROMARK BIOSCIENCES S.À R.L. LLC; ROMARK LABORATORIES, L.C.
To: U.S. BANK NATIONAL ASSOCIATION
Reel/Frame 044472/0001 →